Danone experienced a rise in sales towards the end of last year, driven by strong demand for its protein-rich yogurts and fortified beverages designed for cancer patients. Bloomberg posted on X, highlighting the company's successful performance in these product categories. The growth reflects a broader consumer trend towards health-focused food options, which has benefited Danone's portfolio. The company's strategic focus on nutrition and health has positioned it well in the market, contributing to its positive sales trajectory.